Glow Blend (BPC-157 / TB-500 / GHK-Cu 10/10/50mg)

Glow Blend (BPC-157 / TB-500 / GHK-Cu 10/10/50mg) – Research Overview

Glow Blend is a research-grade triple-peptide formulation combining BPC-157 (10mg), TB-500 (10mg), and GHK-Cu (50mg) in a single lyophilized vial. Each compound targets a distinct biological pathway studied in preclinical tissue repair, cellular migration, and skin biology research models.

What the Research Shows

BPC-157 (10mg) has over 100 preclinical studies documenting VEGFR2 activation, Akt-eNOS signaling, and fibroblast migration enhancement (DOI: 10.1007/s00109-016-1488-y). TB-500 (10mg) operates through actin polymerization and cytoskeletal dynamics to promote cell migration (PMID: 17084833). GHK-Cu (50mg) is a naturally occurring copper-binding tripeptide first isolated from human plasma in 1973. A 2018 review documented GHK-Cu’s modulation of over 4,000 human genes across tissue repair and anti-inflammatory pathways (DOI: 10.3390/ijms19071987). A 2015 review documented GHK-Cu stimulation of collagen synthesis at nanomolar concentrations (DOI: 10.1155/2015/648108).

The combination allows researchers to examine BPC-157’s vascular mechanisms, TB-500’s cytoskeletal migration pathways, and GHK-Cu’s collagen and gene expression effects simultaneously. None of the three compounds are approved by the FDA for human or veterinary therapeutic use.

Quality Documentation

• 99%+ purity — HPLC and Mass Spectrometry verified
• BPC-157 10mg + TB-500 10mg + GHK-Cu 50mg per vial
• Batch-specific COA included with every order
• USA tested and fulfilled

Read the GHK-Cu research overview

Read the BPC-157 and TB-500 research overview

For laboratory research purposes only. Not for human or veterinary consumption.